Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam
· Delayed Price · Currency is VND 56,400
-600 (-1.05%)
At close: Apr 14, 2025
HNX:DP3 Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 11, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 1,178,196 | 1,253,446 | 1,408,246 | 808,400 | 971,800 | 746,480 | Upgrade
|
| Market Cap Growth | -10.99% | -10.99% | 74.20% | -16.81% | 30.18% | 17.30% | Upgrade
|
| Enterprise Value | 836,503 | 929,277 | 1,160,824 | 640,122 | 859,776 | 625,475 | Upgrade
|
| Last Close Price | 54800.00 | 55479.03 | 59751.45 | 31646.29 | 36075.15 | 26165.97 | Upgrade
|
| PE Ratio | 9.72 | 10.34 | 11.24 | 7.43 | 10.31 | 6.55 | Upgrade
|
| PS Ratio | 2.82 | 3.00 | 3.44 | 1.67 | 2.55 | 1.89 | Upgrade
|
| PB Ratio | 2.27 | 2.42 | 3.01 | 1.94 | 2.65 | 2.15 | Upgrade
|
| P/TBV Ratio | 2.36 | 2.51 | 3.14 | 1.97 | 2.70 | 2.19 | Upgrade
|
| P/FCF Ratio | 13.03 | 13.86 | 9.60 | 9.61 | 37.58 | 13.79 | Upgrade
|
| P/OCF Ratio | 12.82 | 13.64 | 9.20 | 8.15 | 36.94 | 6.10 | Upgrade
|
| EV/Sales Ratio | 2.00 | 2.23 | 2.83 | 1.32 | 2.26 | 1.58 | Upgrade
|
| EV/EBITDA Ratio | 5.59 | 6.21 | 7.69 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 6.12 | 6.80 | 8.48 | 5.01 | 7.67 | 4.69 | Upgrade
|
| EV/FCF Ratio | 9.25 | 10.27 | 7.91 | 7.61 | 33.24 | 11.56 | Upgrade
|
| Debt / Equity Ratio | - | - | 0.02 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.05 | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | 0.05 | 0.06 | 0.14 | 0.10 | Upgrade
|
| Asset Turnover | 0.71 | 0.71 | 0.76 | 1.02 | 0.86 | 0.97 | Upgrade
|
| Inventory Turnover | 2.94 | 2.94 | 2.10 | 2.17 | 1.90 | 2.17 | Upgrade
|
| Quick Ratio | 4.29 | 4.29 | 3.26 | 2.60 | 2.31 | 1.97 | Upgrade
|
| Current Ratio | 4.88 | 4.88 | 3.79 | 3.43 | 3.22 | 2.69 | Upgrade
|
| Return on Equity (ROE) | 24.55% | 24.55% | 28.28% | 27.77% | 26.46% | 35.19% | Upgrade
|
| Return on Assets (ROA) | 14.50% | 14.50% | 15.87% | 16.76% | 15.81% | 20.51% | Upgrade
|
| Return on Capital (ROIC) | 17.17% | 17.17% | 19.03% | 20.16% | 19.43% | 25.17% | Upgrade
|
| Return on Capital Employed (ROCE) | 26.30% | 26.30% | 29.20% | 30.60% | 30.60% | 38.50% | Upgrade
|
| Earnings Yield | 1028.45% | 9.67% | 8.89% | 13.46% | 9.70% | 15.28% | Upgrade
|
| FCF Yield | 767.72% | 7.22% | 10.42% | 10.41% | 2.66% | 7.25% | Upgrade
|
| Dividend Yield | 555.55% | - | 5.02% | - | 6.65% | - | Upgrade
|
| Payout Ratio | 5321.46% | 53.22% | 54.84% | 45.84% | 70.55% | 52.76% | Upgrade
|
| Buyback Yield / Dilution | - | - | 5.00% | -5.27% | 0.00% | 2.18% | Upgrade
|
| Total Shareholder Return | 555.55% | - | 10.02% | -5.27% | 6.65% | 2.18% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.